- info@novaerus.ie
- +353 (1) 255 1536
To evaluate the efficacy of the NV200 on reducing Mycobacterium tuberculosis.
The NV200 unit was placed inside a 68 litre plastic enclosure. The plastic enclosure and test set up was placed inside a biosafety cabinet. Clinical isolate of Mycobacterium tuberculosis was aseptically transferred into a sterile mycobacteria growth indicator tube (MGIT) and Lowenstein-Jensen (LJ) medium.
The air sample collected from the test after being exposed to the NV200 showed no growth of Mycobacterium tuberculosis. This shows that the device has effectively rendered all airborne Mycobacterium tuberculosis non-viable.
About Us
Novaerus is on a mission to reduce indoor airborne pollutants that lead to infection, allergies, asthma, and odour.
The patented plasma NanoStrike technology used in Novaerus portable devices was invented in Ireland in 2006.
Novaerus Devices
Stay Connected to Novaerus
To keep up to date with all developments and for the latest research and scientifically proven results please follow us on LinkedIn, Facebook and Youtube.
